InsidersTradesSigma
Follow the Hua Medicine - B share price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Market capitalisation: €2.5bn. The latest transaction was disclosed on 16 July 2026 (Other). Among the most active insiders: Chen Li. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Hua Medicine es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para la diabetes tipo 2. Se concentra en la investigación y comercialización de fármacos basados en la modulación de la vía de la insulina.